Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.

Vibrio cholerae is a bacterial pathogen which causes the severe acute diarrheal disease cholera. Given that a symptomatic incident of cholera can lead to long term protection, a thorough understanding of the immune response to this pathogen is needed to identify parameters critical to the generation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Oluwaseyi Adekunle, Alexandra Dretler, Robert C Kauffman, Alice Cho, Nadine Rouphael, Jens Wrammert
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/4c1faa183adb4642b7767b0c8cf5ce78
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c1faa183adb4642b7767b0c8cf5ce78
record_format dspace
spelling oai:doaj.org-article:4c1faa183adb4642b7767b0c8cf5ce782021-12-02T20:24:11ZLongitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.1935-27271935-273510.1371/journal.pntd.0009743https://doaj.org/article/4c1faa183adb4642b7767b0c8cf5ce782021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009743https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735Vibrio cholerae is a bacterial pathogen which causes the severe acute diarrheal disease cholera. Given that a symptomatic incident of cholera can lead to long term protection, a thorough understanding of the immune response to this pathogen is needed to identify parameters critical to the generation and durability of immunity. To approach this, we utilized a live attenuated cholera vaccine to model the response to V. cholerae infection in 12 naïve subjects. We found that this live attenuated vaccine induced durable vibriocidal antibody titers that were maintained at least one year after vaccination. Similar to what we previously reported in infected patients from Bangladesh, we found that vaccination induced plasmablast responses were primarily specific to the two immunodominant antigens lipopolysaccharide (LPS) and cholera toxin (CT). Interestingly, the magnitude of the early plasmablast response at day 7 predicted the serological outcome of vaccination at day 30. However, this correlation was no longer present at later timepoints. The acute responses displayed preferential immunoglobulin isotype usage, with LPS specific cells being largely IgM or IgA producing, while cholera toxin responses were predominantly IgG. Finally, CCR9 was highly expressed on vaccine induced plasmablasts, especially on IgM and IgA producing cells, suggesting a role in migration to the gastrointestinal tract. Collectively, these findings demonstrate that the use of a live attenuated cholera vaccine is an effective tool to examine the primary and long-term immune response following V. cholerae exposure. Additionally, it provides insight into the phenotype and specificity of the cells which likely return to and mediate immunity at the intestinal mucosa. A thorough understanding of these properties both in peripheral blood and in the intestinal mucosae will inform future vaccine development against both cholera and other mucosal pathogens. Trial Registration: NCT03251495.Oluwaseyi AdekunleAlexandra DretlerRobert C KauffmanAlice ChoNadine RouphaelJens WrammertPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 9, p e0009743 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Oluwaseyi Adekunle
Alexandra Dretler
Robert C Kauffman
Alice Cho
Nadine Rouphael
Jens Wrammert
Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
description Vibrio cholerae is a bacterial pathogen which causes the severe acute diarrheal disease cholera. Given that a symptomatic incident of cholera can lead to long term protection, a thorough understanding of the immune response to this pathogen is needed to identify parameters critical to the generation and durability of immunity. To approach this, we utilized a live attenuated cholera vaccine to model the response to V. cholerae infection in 12 naïve subjects. We found that this live attenuated vaccine induced durable vibriocidal antibody titers that were maintained at least one year after vaccination. Similar to what we previously reported in infected patients from Bangladesh, we found that vaccination induced plasmablast responses were primarily specific to the two immunodominant antigens lipopolysaccharide (LPS) and cholera toxin (CT). Interestingly, the magnitude of the early plasmablast response at day 7 predicted the serological outcome of vaccination at day 30. However, this correlation was no longer present at later timepoints. The acute responses displayed preferential immunoglobulin isotype usage, with LPS specific cells being largely IgM or IgA producing, while cholera toxin responses were predominantly IgG. Finally, CCR9 was highly expressed on vaccine induced plasmablasts, especially on IgM and IgA producing cells, suggesting a role in migration to the gastrointestinal tract. Collectively, these findings demonstrate that the use of a live attenuated cholera vaccine is an effective tool to examine the primary and long-term immune response following V. cholerae exposure. Additionally, it provides insight into the phenotype and specificity of the cells which likely return to and mediate immunity at the intestinal mucosa. A thorough understanding of these properties both in peripheral blood and in the intestinal mucosae will inform future vaccine development against both cholera and other mucosal pathogens. Trial Registration: NCT03251495.
format article
author Oluwaseyi Adekunle
Alexandra Dretler
Robert C Kauffman
Alice Cho
Nadine Rouphael
Jens Wrammert
author_facet Oluwaseyi Adekunle
Alexandra Dretler
Robert C Kauffman
Alice Cho
Nadine Rouphael
Jens Wrammert
author_sort Oluwaseyi Adekunle
title Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
title_short Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
title_full Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
title_fullStr Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
title_full_unstemmed Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
title_sort longitudinal analysis of human humoral responses after vaccination with a live attenuated v. cholerae vaccine.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/4c1faa183adb4642b7767b0c8cf5ce78
work_keys_str_mv AT oluwaseyiadekunle longitudinalanalysisofhumanhumoralresponsesaftervaccinationwithaliveattenuatedvcholeraevaccine
AT alexandradretler longitudinalanalysisofhumanhumoralresponsesaftervaccinationwithaliveattenuatedvcholeraevaccine
AT robertckauffman longitudinalanalysisofhumanhumoralresponsesaftervaccinationwithaliveattenuatedvcholeraevaccine
AT alicecho longitudinalanalysisofhumanhumoralresponsesaftervaccinationwithaliveattenuatedvcholeraevaccine
AT nadinerouphael longitudinalanalysisofhumanhumoralresponsesaftervaccinationwithaliveattenuatedvcholeraevaccine
AT jenswrammert longitudinalanalysisofhumanhumoralresponsesaftervaccinationwithaliveattenuatedvcholeraevaccine
_version_ 1718374048745914368